Literature DB >> 26802701

Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.

Jiraphong Suksiriworapong1, Kittisak Phoca2, Supakanda Ngamsom2, Kittisak Sripha3, Primchanien Moongkarndi4, Varaporn Buraphacheep Junyaprasert5.   

Abstract

This study aimed to investigate the effect of the different hydrophobic chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl polyethylene glycol 1000 succinate (P(CL)-TPGS) copolymers on the nanoparticle properties and delivery efficiency of quercetin to SKBR3 breast cancer cells. The 5:1, 10:1 and 20:1 P(CL)-TPGS copolymers were fabricated and found to be composed of 25.0%, 45.2% and 66.8% of hydrophobic P(CL) chains with respect to the polymer chain, respectively. The DSC measurement indicated the microphase separation of P(CL) and TPGS segments. The crystallization of P(CL) segment occurred when the P(CL) chain was higher than 25% due to the restricted mobility of P(CL) by TPGS. The longer P(CL) chain had the higher crystallinity while decreasing the crystallinity of TPGS segment. The increasing P(CL) chain length increased the particle size of P(CL)-TPGS nanoparticles from 20 to 205 nm and enhanced the loading capacity of quercetin due to the more hydrophobicity of the nanoparticle core. The release of quercetin was retarded by an increase in P(CL) chain length associated with the increasing hydrophobicity and crystallinity of P(CL)-TPGS copolymers. The P(CL)-TPGS nanoparticles potentiated the toxicity of quercetin to SKBR3 cells by at least 2.9 times compared to the quercetin solution. The cellular uptake of P(CL)-TPGS nanoparticles by SKBR3 cells occurred through cholesterol-dependent endocytosis. The 10:1 P(CL)-TPGS nanoparticles showed the highest toxicity and uptake efficiency and could be potentially used for the delivery of quercetin to breast cancer cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amiloride hydrochloride hydrate (PubChem CID: 23581809); Caprolactone (PubChem CID: 10401); Chlorpromazine hydrochloride (PubChem CID: 6240); Filipin III (PubChem CID: 5351457); Hydrophobic chain length; Nanoparticles; Poloxamer 407 (PubChem CID: 24751); Poly(ε-caprolactone); Quercetin; Quercetin (PubChem CID: 5280343); TPGS (PubChem CID: 71406); d-α-Tocopheryl polyethylene glycol 1000 succinate; β-Cyclodextrin (PubChem CID: 6518168)

Mesh:

Substances:

Year:  2016        PMID: 26802701     DOI: 10.1016/j.ejpb.2016.01.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

Review 1.  Molecular mechanisms of action of quercetin in cancer: recent advances.

Authors:  Dharambir Kashyap; Sonam Mittal; Katrin Sak; Paavan Singhal; Hardeep Singh Tuli
Journal:  Tumour Biol       Date:  2016-07-22

Review 2.  Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.

Authors:  Conglian Yang; Tingting Wu; Yan Qi; Zhiping Zhang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

3.  Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery.

Authors:  Kang Liu; Weijuan Chen; Tingting Yang; Baofang Wen; Dejun Ding; Michael Keidar; Jinbao Tang; Weifen Zhang
Journal:  Int J Nanomedicine       Date:  2017-11-13

4.  Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.

Authors:  Shuangming Kang; Wenjuan Duan; Shangqian Zhang; Dawei Chen; Jianfang Feng; Na Qi
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

5.  Design and Development of D‒α‒Tocopheryl Polyethylene Glycol Succinate‒block‒Poly(ε-Caprolactone) (TPGS-b-PCL) Nanocarriers for Solubilization and Controlled Release of Paclitaxel.

Authors:  Osman Yusuf; Raisuddin Ali; Abdullah H Alomrani; Aws Alshamsan; Abdullah K Alshememry; Abdulaziz M Almalik; Afsaneh Lavasanifar; Ziyad Binkhathlan
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.